|
|
|
Volumn 36, Issue SUPPL. 1, 1999, Pages 42-56
|
|
Antithrombin agents as anticoagulants and antithrombotics: Implications in drug development
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACTIVATED PROTHROMBIN COMPLEX;
ALTEPLASE;
ANTICOAGULANT AGENT;
ARGATROBAN;
ARGIPRESSIN[1 DEAMINO];
BAZOTROXOBIN;
BLOOD CLOTTING FACTOR 13;
BLOOD CLOTTING FACTOR 5;
BLOOD CLOTTING FACTOR 8 BYPASS INHIBITOR;
CVS 995;
DESULFATOHIRUDIN;
DEXTRO PHENYLALANYLPROLYLARGININAL;
EFEGATRAN;
FIBRIN;
HEPARIN;
HIRUDIN;
HIRULOG;
LEPIRUDIN;
NAPSAGATRAN;
TERT BUTYLOXYCARBONYL DEXTRO PHENYLALANYLPROLYLARGININAL;
THROMBIN INHIBITOR;
UNCLASSIFIED DRUG;
VASOPRESSIN DERIVATIVE;
ANTICOAGULATION;
CLINICAL TRIAL;
CONFERENCE PAPER;
DRUG MECHANISM;
DRUG PROTEIN BINDING;
DRUG SAFETY;
DRUG STRUCTURE;
HEALTH CARE COST;
HEPARINIZATION;
HISTORY OF MEDICINE;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
META ANALYSIS;
PATHOPHYSIOLOGY;
PRIORITY JOURNAL;
PROTEIN STRUCTURE;
THROMBOCYTOPENIA;
THROMBOSIS;
THROMBOSIS PREVENTION;
AMINO ACID SEQUENCE;
ANTICOAGULANTS;
ANTITHROMBINS;
BLOOD COAGULATION DISORDERS;
DRUG DESIGN;
FIBRINOLYTIC AGENTS;
MOLECULAR SEQUENCE DATA;
|
|
EID: 0032900769
PISSN: 00371963
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (30)
|
|
References (88)
|
